Supriya Lifescience Limited (SUPRIYA.BO)
INR 638.45
(-0.98%)
INR 638.45
(-0.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.7 Billion INR | 26.46% |
| 2022 | 4.51 Billion INR | -13.16% |
| 2021 | 5.19 Billion INR | 34.77% |
| 2020 | 3.85 Billion INR | 23.66% |
| 2019 | 3.11 Billion INR | 12.17% |
| 2018 | 2.77 Billion INR | 30.49% |
| 2017 | 2.12 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.6 Billion INR | 1.55% |
| 2024 Q2 | 1.66 Billion INR | 3.41% |
| 2023 Q2 | 1.4 Billion INR | 6.12% |
| 2023 Q1 | 1.32 Billion INR | -0.25% |
| 2023 Q4 | 1.58 Billion INR | 12.93% |
| 2023 FY | 5.7 Billion INR | 26.46% |
| 2023 Q3 | 1.4 Billion INR | -0.01% |
| 2022 Q4 | 1.32 Billion INR | 25.88% |
| 2022 Q3 | 1.05 Billion INR | -6.27% |
| 2022 Q2 | 1.12 Billion INR | 10.67% |
| 2022 Q1 | 1.01 Billion INR | -42.92% |
| 2022 FY | 4.51 Billion INR | -13.16% |
| 2021 Q1 | 769.42 Million INR | -40.65% |
| 2021 FY | 5.19 Billion INR | 34.77% |
| 2021 Q4 | 1.77 Billion INR | 51.77% |
| 2021 Q3 | 1.17 Billion INR | -20.87% |
| 2021 Q2 | 1.47 Billion INR | 92.17% |
| 2020 Q3 | 806.91 Million INR | 0.0% |
| 2020 FY | 3.85 Billion INR | 23.66% |
| 2020 Q4 | 1.29 Billion INR | 60.67% |
| 2019 FY | 3.11 Billion INR | 12.17% |
| 2018 FY | 2.77 Billion INR | 30.49% |
| 2017 FY | 2.12 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 31.27 Million INR | -18138.417% |
| Biocon Limited | 147.55 Billion INR | 96.135% |
| Blue Jet Healthcare Limited | 7.11 Billion INR | 19.847% |
| Concord Biotech Limited | 10.16 Billion INR | 43.913% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 78.195% |
| FERMENTA BIOTECH LIMITED | 3.35 Billion INR | -69.924% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -345421.733% |
| Lyka Labs Limited | 1.05 Billion INR | -442.526% |
| Panacea Biotec Limited | 5.51 Billion INR | -3.341% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 3.05 Billion INR | -86.421% |
| Syngene International Limited | 34.88 Billion INR | 83.65% |
| TAKE Solutions Limited | 656.08 Million INR | -769.36% |
| Titan Biotech Limited | 1.64 Billion INR | -247.634% |
| Transgene Biotek Limited | 2.34 Million INR | -242713.963% |
| Vanta Bioscience Limited | 97.22 Million INR | -5766.254% |